Variation in MT expression in early-stage depressed-type and polypoid-type colorectal tumours

European Journal of Cancer

Volumn 38, Issue 14, 2002, Pages 1879-1887

  Kuroda, K ^a,b   Aoyama, N ^a   Tamura, T ^a   Sakashita, M ^a   Maekawa, S ^a   Inoue, T ^a   Wambura, C ^a   Shirasaka, D ^a   Minami, R ^a   Maeda, S ^a   Kuroda, Y ^a   Kasuga, M ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Colorectal carcinoma; Depressed type; Immunohistochemistry; Metallothionein; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; METALLOTHIONEIN;

ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER STAGING; CELL STRUCTURE; COLORECTAL CARCINOMA; COLORECTAL TUMOR; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; METALLOTHIONEIN; MIDDLE AGED; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0036710209     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00233-2     Document Type: Article

References (30)

1. Nath R., Kambadur R., Gulati S., Paliwal V.K., Sharma M. Molecular aspects, physiological functions, and clinical significance of metallothioneins. Critical Rev. Food Sci. Nutr. 27:1988;41-85.
2. Kelly S.L., Basu A., Teicher B.A., Hacker M.P., Hamer D.H., Lazo J.S. Overexpression of metallothionein confers resistance to anticancer drugs. Science. 241:1998;1813-1815.
3. Thornalley P.J., Vasàk M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta. 827:1985;36-44.
4. Jasani B., Schmid K.W. Significance of metallothionein overexpression in human tumours. Histopathology. 31:1997;211-214.
5. Fresno M., Wu W., Rodriguez J.M., Nadji M. Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Arch [A]. 423:1993;215-219.
6. Zelger B., Hittmair A., Schir M.et al. Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology. 23:1993;257-264.
7. Ohshio G., Imamura T., Okada N.et al. Immunohistochemical study of metallothionein in pancreatic carcinomas. J. Cancer Res. Clin. Oncol. 122:1996;351-355.
8. Öfner D., Maier H., Riedmann B.et al. Immunohistochemical metallothionein expression in colorectal adenocarcinoma. correlation with tumour stage and patient survival Virchows Arch [A]. 425:1994;491-497.
9. Giuffrè G., Barresi G., Sturniolo G.C., Sarnelli R., D'incà R., Tuccari G. Immunohistochemical expression of metallothionein in normal human colorectal mucosa, in adenomas and in adenocarcinomas and their associated metastasis. Histopathology. 29:1996;347-354.
10. Ioachim E.E., Goussia A.C., Agnantis N.J., Machera M., Tsianos E.V., Kappas A.M. Prognostic evaluation of metallothionein expression in human colorectal neoplasms. J. Clin. Pathol. 52:1999;876-879.
11. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
12. Mueller J., Mueller E., Hoepner I.et al. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma. a comparative immunohistochemical study J. Pathol. 180:1996;259-265.
13. Hart A.R., Kudo S., Mackay E.H., Mayberry J.F., Atkin W.S. Flat adenomas exist in asymptomatic people. important implications for colorectal cancer screening programmes Gut. 43:1998;229-231.
14. Mueller J.D., Haegle N., Keller G.et al. Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum. Am. J. Pathol. 153:1998;1977-1984.
15. Bedenne L., Faivre J., Boutron M.C., Piard F., Cauvin J.M., Hillon P. Adenoma-carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer. 69:1992;883-888.
16. Kudo S., Tamura S., Hirota S.et al. The problem of De Novo colorectal carcinoma. Eur. J. Cancer. 31A:1995;1118-1120.
17. Kudo S., Tamura S., Nakajima T.et al. Depressed type of colorectal cancer. Endoscopy. 27:1995;54-57.
18. Hall P.A., Levison D.A., Woods A.L.et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections. an index of cell proliferation with evidence of deregulated expression in some neoplasms J. Pathol. 162:1990;285-294.
19. Teixeira C.R., Tanaka S., Haruma K., Yoshihara M., Sumii K., Kajiyama G. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer. 73:1994;575-579.
20. Sobin LH, Wittekind Ch, eds. (International Union Against Cancer). TNM Classification of Malignant Tumours, 5th ed., New York, John Wiley, 1997.
21. Sakashita M., Aoyama N., Maekawa S.et al. Flat-elevated and depressed, subtypes of flat early colorectal cancers, should be distinguished by their pathological features. Int. J. Colorectal Dis. 15:2000;275-281.
22. Mulder T.P.J., Verspaget H.W., Janssens A.R., De Bruin P.A.F., Griffioen G., Lamers C.B.H.W. Neoplasia-related changes of two copper (Cu)/zinc (Zn) proteins in the human colon. Free Radic. Biol. Med. 10:1990;501-506.
23. Sakashita M., Aoyama N., Minami R.et al. Glut1 expression in T1 and T2 stage colorectal carcinomas. its relationship to clinicopathological features Eur. J. Cancer. 37:2001;204-209.
24. Hiddemann W., Von Bassewitz D.B., Kleinemeier H.J.et al. DNA stemline heterogeneity in colorectal cancer. Cancer. 58:1986;258-263.
25. Dexter D.L., Spremulli E.N., Fligiel Z.et al. Heterogeneity of cancer cells from a single human colon carcinoma. Am. J. Med. 71:1981;949-956.
26. Minamoto T., Sawaguchi K., Mai M., Yamashita N., Sugimura T., Esumi H. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res. 54:1994;2841-2844.
27. Fujimori T., Satonaka K., Yamamura-Idei Y., Nagasako K., Maeda S. Non-involvement of ras mutations in flat colorectal adenomas and carcinomas. Int. J. Cancer. 57:1994;51-55.
28. Hayakawa M., Shimokawa K., Kusugami K.et al. Clinicopathological features of superficial depressed-type colorectal neoplastic lesions. Am. J. Gastroenterol. 94:1999;944-949.
29. Yukawa M., Fujimori T., Maeda S., Tabuchi M., Nagasako K. Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours. Gut. 35:1994;1258-1261.
30. Hirota S., Kudo S., Hosobe S.et al. p53 immunoreactive stain and early colorectal adenocarcinomas. Eur. J. Cancer. 31A:1995;2220-2222.